Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 2, 2020

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: A meta-analysis

You mean this from March 2015 wasn't good enough?

But you need to know none of this since your doctor will know about this study from March 2015 and have already updated your drug taking protocols. 

Where Can I Find A List of Anticholinergic Drugs?

 

Notice that baclofen, Tizanidine (Zanaflex) and Zantac may have some anticholinergic activity.

Cumulative Use of Strong Anticholinergics and Incident Dementia March 2015

The latest here:

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: A meta-analysis


Pieper NT, Grossi CM, Chan WY, et al
Age and Aging|July 1, 2020
A systematic review and meta-analysis was performed to examine the link between anticholinergic drugs and the risk of dementia, mild cognitive impairment and cognitive decline among older people, to ultimately clarify the long-term impact of anticholinergic drugs on cognitive function. For this purpose, the relevant studies with ≥12 weeks follow-up, published between January 2002 and April 2018, were identified. This analysis included 26 studies with 621,548 participants. Findings from observational studies showed increased dementia incidence and cognitive decline in correlation with anticholinergic drug use. Since studies were observational with considerable risk of bias, so, experts could not conclude a causal link. To guide the management of long-term use, stronger evidence from high-quality studies is required.
Read the full article on Age and Aging.

No comments:

Post a Comment